GW Pharma's marijuana-derived epilepsy drug sales continue to climb
February 25, 2020 at 16:23 PM EST
GW Pharmaceuticals Inc. reported revenue that topped the consensus estimates Tuesday, as the company’s marijuana-derived epilepsy drug continue to grow.